WallStreetZenWallStreetZen

NASDAQ: CGEM
Cullinan Therapeutics Inc Stock Ownership - Who owns Cullinan Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Cullinan Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Corrine SavillChief Business Officer2024-02-0140,000$4.30
$172.00kBuy
Corrine SavillChief Business Officer2024-02-0140,000$16.18
$647.20kSell
Corrine SavillChief Business Officer2024-01-2940,000$4.30
$172.00kBuy
Corrine SavillChief Business Officer2024-01-2940,000$14.09
$563.60kSell
Corrine SavillChief Business Officer2024-01-2321,316$4.30
$91.66kBuy
Corrine SavillChief Business Officer2024-01-2321,316$12.46
$265.60kSell
Corrine SavillChief Business Officer2024-01-2214,559$4.30
$62.60kBuy
Corrine SavillChief Business Officer2024-01-224,125$12.02
$49.58kSell
Corrine SavillChief Business Officer2024-01-2214,559$12.18
$177.33kSell
Nadim AhmedPresident and CEO2023-12-264,272$9.24
$39.47kSell

1 of 4

CGEM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CGEM insiders and whales buy or sell their stock.

CGEM Shareholders

What type of owners hold Cullinan Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ansbert Gadicke37.52%16,157,644$269.35MInsider
Ubs Oncology Impact Fund LP17.76%7,648,268$127.50MInsider
Mpm Bioimpact LLC17.76%7,648,268$127.50MInstitution
Morana Jovanembiricos10.75%4,631,022$77.20MInsider
Vision Scs F210.39%4,476,350$74.62MInsider
F2 Bioscience I 2017 Ltd10.29%4,430,964$73.86MInsider
Blue Owl Capital Holdings LP7.94%3,419,842$57.01MInstitution
Franklin Resources Inc7.62%3,281,280$54.70MInstitution
Bvf Inc7.42%3,196,701$53.29MInstitution
Blackrock Inc5.72%2,462,274$41.05MInstitution

1 of 3

CGEM vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CGEM48.26%51.74%Net SellingNet Buying
ELVN46.22%53.78%Net SellingNet Selling
COGT87.38%11.29%Net BuyingNet Buying
PRTC0.00%0.00%
RGNX76.15%23.85%Net SellingNet Buying
View Top Biotech Stocks

Cullinan Therapeutics Stock Ownership FAQ

Who owns Cullinan Therapeutics?

Cullinan Therapeutics (NASDAQ: CGEM) is owned by 85.59% institutional shareholders, 91.75% Cullinan Therapeutics insiders, and 0.00% retail investors. Ansbert Gadicke is the largest individual Cullinan Therapeutics shareholder, owning 16.16M shares representing 37.52% of the company. Ansbert Gadicke's Cullinan Therapeutics shares are currently valued at $269.35M.

If you're new to stock investing, here's how to buy Cullinan Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.